Europe
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Paris-based Sanofi signed the lease on two buildings yet to be built in East Cambridge, Massachusetts. Sanofi is the state’s largest life science employer and plans to shift 2,700 staffers into the two buildings at Cambridge Crossing.
CARMAT and the European Investment Bank today announce the signing of a €30 million loan agreement supported by the European Fund for Strategic Investments (EFSI)
This crucial step has allowed the Company to launch the final preclinica development required by the authorities ahead of a clinical trial
Promore Pharma AB today announced that the company’s partner and third largest shareholder PharmaResearch Products Ltd (PRP) has chosen to exercise the call option granted by the other main shareholders Midroc New Technology AB (Midroc) and Rosetta Capital IV Sarl (Rosetta) in May 2017.
Strategic business expert brings broad expertise at a crucial time in UV-C high-level disinfection
Rentschler Biopharma SE announced today that the Company has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA, USA.
Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence
BioGeneration Ventures is pleased to announce that its portfolio company Staten Biotechnology B.V. and Novo Nordisk A/S have entered into a collaboration and exclusive option agreement.
Data Safety Monitoring Board (DSMB) recommended the continuation of RESOLVE-IT without any modifications, based on the pre-planned review of safety data, including adverse events and laboratory data
PRESS RELEASES